Grant Skrepnek to Antipsychotic Agents
This is a "connection" page, showing publications Grant Skrepnek has written about Antipsychotic Agents.
Connection Strength
2.373
-
Adherence, Persistence, Readmissions, and Costs in Medicaid Members with Schizophrenia or Schizoaffective Disorder Initiating Paliperidone Palmitate Versus Switching Oral Antipsychotics: A Real-World Retrospective Investigation. Adv Ther. 2023 Jan; 40(1):349-366.
Score: 0.804
-
Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia. Curr Med Res Opin. 2022 Sep; 38(9):1621-1630.
Score: 0.789
-
A National Assessment of Alzheimer Disease and Antipsychotic Medication Prescribing Among Older Adults in Ambulatory Care Settings. Alzheimer Dis Assoc Disord. 2022 Jul-Sep 01; 36(3):230-237.
Score: 0.781